(Q41151987)

27 September 2017

title

Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells (English)

1 reference

27 September 2017

1 reference

1 reference

R De Vincenzo

1

1 reference

27 September 2017

G Scambia

2

1 reference

27 September 2017

P Benedetti Panici

3

1 reference

27 September 2017

A Fattorossi

4

1 reference

27 September 2017

G Bonanno

5

1 reference

27 September 2017

C Ferlini

6

1 reference

27 September 2017

G Isola

7

1 reference

27 September 2017

S Pernisco

8

1 reference

27 September 2017

S Mancuso

9

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

International Journal of Cancer

27 September 2017

published in

1 reference

27 September 2017

volume

68

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

340-348

1 reference

Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Tamoxifen inhibits uptake and metabolism of ethanolamine and choline in multidrug-resistant, but not in drug-sensitive, MCF-7 human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Use of fluorescent dyes as molecular probes for the study of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Clinical trials of agents that reverse multidrug resistance. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Antiestrogens and steroid hormones: substrates of the human P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

The future of new pure antiestrogens in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819961104%2968%3A3%3C340%3A%3AAID-IJC12%3E3.0.CO%3B2-C

10.1002/(SICI)1097-0215(19961104)68:3<340::AID-IJC12>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference